Evidence map›Paper›PMID 30710463›Full record

ArticleMolecular microbiology2019

Controlling chronic Pseudomonas aeruginosa infections by strategically interfering with the sensory function of SagS.

Jozef Dingemans, Rebecca E Al-Feghali, Gee W Lau, Karin Sauer

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jozef DingemansDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA.ORCID 0000-0001-8079-3087
Rebecca E Al-FeghaliDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA.
Gee W LauDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL, 61802, USA.ORCID 0000-0002-7962-3950
Karin SauerDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA.ORCID 0000-0002-1177-6328
Binghamton University · USUniversity of Illinois Urbana-Champaign · US

Funding

Role of PA4878 in biofilm antimicrobial resistanceR01AI080710 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI LAU, GEE W, SAUER, KARIN · 2009 to 2020
$3.1M
Role of SagS signaling and regulatory events in biofilm formation and toleranceR21AI119726 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI SAUER, KARIN · 2015 to 2016
$426k
NIAID NIH HHS R01 AI080710NIAID NIH HHS R21 AI119726
6 · The paper itself

Abstract

The hybrid sensor SagS plays a central role in the formation of Pseudomonas aeruginosa biofilms, by enabling the switch from the planktonic to the biofilm mode of growth and by facilitating the transition of biofilm cells to a highly tolerant state. In this study, we examined the importance of the SagS key amino acid residues associated with biofilm formation (L154) and antibiotic tolerance (D105) in P. aeruginosa virulence. Recombinant P. aeruginosa ΔsagS and ΔsagS chromosomally expressing wild-type sagS, or its two variants D105A and L154A, were tested for their potential to form biofilms and cause virulence in plants and mouse models of acute and chronic pneumonia. Although mutation of sagS did not alter P. aeruginosa virulence during acute infections, a significant difference in pathogenicity of sagS mutants was observed during chronic infections, with the L154A variant showing reduced bacterial loads in the chronic pneumonia model, while interference with the D105 residue enhanced the susceptibility of P. aeruginosa biofilms during tobramycin treatment. Our findings suggest that interference with the biofilm or tolerance regulatory circuits of SagS affects P. aeruginosa pathogenicity in chronic but not acute infections, and reveal SagS to be a promising new target to treat P. aeruginosa biofilm infections.

Indexed as

Amino AcidsAnimalsAnti-Bacterial AgentsArabidopsisBacterial ProteinsBiofilmsChronic DiseaseFemaleGene Expression Regulation, BacterialMaleMiceMice, Inbred BALB CMutationPneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsAmino AcidsAnti-Bacterial AgentsBacterial Proteins

Identifiers

PMID30710463
PMCPMC6488366
OpenAlexW2914644249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.